Welcome to LookChem.com Sign In|Join Free

CAS

  • or

107052-56-2

107052-56-2

Post Buying Request

107052-56-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107052-56-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 107052-56-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,0,5 and 2 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 107052-56:
(8*1)+(7*0)+(6*7)+(5*0)+(4*5)+(3*2)+(2*5)+(1*6)=92
92 % 10 = 2
So 107052-56-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H22N4O2/c1-23-8-12(9-24-10-18(25)22-19(26)11-24)5-15-14-3-2-4-16-20(14)13(7-21-16)6-17(15)23/h2-5,7,12,17,21H,6,8-11H2,1H3,(H,22,25,26)/t12-,17-/m1/s1

107052-56-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-yl]methyl]piperazine-2,6-dione

1.2 Other means of identification

Product number -
Other names 2,6-Piperazinedione,4-(((8beta)-9,10-didehydro-6-methylergolin-8-yl)methyl)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107052-56-2 SDS

107052-56-2Relevant articles and documents

D1 agonist and/or D2 antagonist dopamine receptor properties of a series of ergoline derivatives: A structure-activity study

Mantegani, Sergio,Arlandini, Emanuele,Bandiera, Tiziano,Borghi, Daniela,Brambilla, Enzo,Caccia, Carla,Cervini, Maria Antonietta,Cremonesi, Paolo,McArthur, Robert Albert,Traquandi, Gabriella,Varasi, Mario

, p. 107 - 124 (2007/10/03)

A series of (3,5-dioxopiperazin-1-yl)ergoline derivatives has been synthesised and evaluated in vitro and in vivo for their dopaminergic D1 and D2 components. The structural contributions to the pharmacological profile of the ergoline skeleton, its substituents on positions 1, 2, 6, 9, and the 3,5-dioxopiperazin-1-yl portion of the molecule were examined. Structure- activity relationships within this series suggested that substitution on the ergoline skeleton in position 1 or 2 and on the 3,5-dioxopiperazin-4-nitrogen generated compounds with a spectrum of dopamine agonistic/antagonistic activity sensitive to both the nature and position of substituents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107052-56-2